Authors: JHINGAN A MARYANOV D LEVON S BRAUKER JH GELLER RL

Citation: A. Jhingan et al., USE OF AN IMMUNOISOLATION DEVICE FOR CANCER-THERAPY - EFFECTS OF SLOW-RELEASE CYTOKINES, Cancer gene therapy, 3(6), 1996, pp. 10-10

Authors: CHRISTIANSEN WT JALBERT LR ROBERTSON RM JHINGAN A PROROK M CASTELLINO FJ

Citation: Wt. Christiansen et al., HYDROPHOBIC AMINO-ACID-RESIDUES OF HUMAN ANTICOAGULATION PROTEIN-C THAT CONTRIBUTE TO ITS FUNCTIONAL BINDING TO PHOSPHOLIPID-VESICLES, Biochemistry, 34(33), 1995, pp. 10376-10382

Authors: JHINGAN A ZHANG L CHRISTIANSEN WT CASTELLINO FJ

Citation: A. Jhingan et al., THE ACTIVITIES OF RECOMBINANT GAMMA-CARBOXYGLUTAMIC-ACID-DEFICIENT MUTANTS OF ACTIVATED HUMAN PROTEIN-C TOWARD HUMAN COAGULATION-FACTOR VA AND FACTOR-VIII IN PURIFIED SYSTEMS AND IN PLASMA, Biochemistry, 33(7), 1994, pp. 1869-1875

Authors: YU SQ ZHANG L JHINGAN A CHRISTIANSEN WT CASTELLINO FJ

Citation: Sq. Yu et al., CONSTRUCTION, EXPRESSION, AND PROPERTIES OF A RECOMBINANT CHIMERIC HUMAN PROTEIN-C WITH REPLACEMENT OF ITS GROWTH FACTOR-LIKE DOMAINS BY THOSE OF HUMAN COAGULATION FACTOR-IX, Biochemistry, 33(3), 1994, pp. 823-831

Authors: JHINGAN A CHRISTIANSEN W ZHANG L CASTELLINO FJ

Citation: A. Jhingan et al., ROLES OF INDIVIDUAL GAMMA-CARBOXYGLUTAMIC ACID RESIDUES OF HUMAN ACTIVATED PROTEIN-C ON ITS ACTIVITY TOWARD COAGULATION FACTOR-VIII AND FACTOR-VA, Thrombosis and haemostasis, 69(6), 1993, pp. 979-979